X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

MYNZ

Closed

Mainz Biomed Bv

1.42
+0.01 (+0.71%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.41
Day's Range: 1.3975 - 1.43
Send
When Written:
 
6.49
Mainz Biomed BV is a Dutch biotech company that focuses on the development and commercialization of innovative therapeutics for the treatment of cancer and other diseases. The company was founded in 2016 and is based in Leiden, the Netherlands. Mainz Biomed BV is a subsidiary of Mainz Biotech Holding GmbH, a German biotech company that specializes in the discovery and development of new drugs for the treatment of cancer and other diseases.

Mainz Biomed BV's pipeline includes several promising drug candidates, including MBG-101, a monoclonal antibody that targets a specific protein expressed on the surface of cancer cells. The company is also developing other novel therapeutics that target various pathways involved in cancer growth and metastasis.

Mainz Biomed BV has partnerships with several leading academic and research institutions, including Leiden University Medical Center, the Netherlands Cancer Institute, and the University of California, San Francisco. The company has also received funding from various sources, including the Dutch government, private investors, and research grants.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X